在COPD和支气管切除中准呼吸道微生物群.
Micheál Mac Aogáin1,2, Pei Yee Tiew3,4,5, Tavleen Kaur Jaggi3
1Department of Biochemistry, St. James's Hospital, Dublin, Ireland.
这篇评论探讨了呼吸道微生物群.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 呼吸道微生物群在慢性呼吸道疾病 (如COPD和支气管病) 中起着至关重要的作用.
- 了解微生物群落与宿主免疫之间的相互作用对于疾病管理至关重要.
研究的目的:
- 审查目前对COPD和支气管病的呼吸道微生物组的理解.
- 探索微生物群落对疾病病理和治疗结果的影响.
- 讨论基于微生物组的治疗方法的潜力.
主要方法:
- 在PubMed和Medline的综合文献搜索 (2010年1月至2024年3月).
- 综合有关气道微生物组动态和分析挑战的当前知识.
- 检查临床相关性和对呼吸道微生物群的治疗影响.
主要成果:
- 呼吸道微生物组显著影响慢性呼吸道疾病.
- 目前的疗法对呼吸道微生物群产生不同的影响.
- 交叉种类对维持呼吸系统健康至关重要.
结论:
- 微生物组导向疗法为治疗COPD和支气管炎症提供了一种有前途的方法.
- 过渡到微生物意识的诊断和治疗需要跨学科的合作.
- 弥合微生物组分析和临床应用之间的差距需要持续的创新.
更多相关视频
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
06:57The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
